Antithrombotic property of an aqueous extract from Pseudocedrela kotschyi and Adenia cissampeloides

Wilson Bright Nyansah , George Asumeng Koffuor, Inemesit Okon Ben, Linda Gyanfosu, Ben Enoluomen Ehigiator

Abstract


Background and purpose: An aqueous extract from the root bark of Pseudocedrela kotschyi and aerial parts of Adenia cissampeloides has been proven in previous research to elicit significant anticoagulant property in vitro. This, therefore, indicates the potential usefulness of this extract in managing thromboembolic disease, a major global health risk. The aim of the present work was to establish the antithrombotic effect of a product made from extracts of the root bark of P. kotschyi and the aerial parts of A. cissampeloides (PAE).

Experimental approach: The effect of PAE at 500-2000 mg/kg in inhibiting tail infarction and inflammation, as well as its effect on the microthrombi count, hematological, and coagulation profiles in a carrageenan-induced thrombosis model in Sprague-Dawley rats, was studied.

Findings/Results: PAE significantly (P ≤ 0.01-0.001) reduced length of tail infarction and inflammation (redness, swelling, pain, and temperature). Histopathological studies revealed a significant reduction                    (P ≤ 0.0001) in microthrombi count in the liver and the lungs with PAE treatment. PAE treatment caused a marginal (P ≤ 0.01) increase in prothrombin time but resulted in a significant (P ≤ 0.01- 0.0001) dose-dependent increase in activated partial thromboplastin time, with the hematological profile being normal.

Conclusion and implications: PAE showed anticoagulant and antithrombotic effects in vivo, indicative of its potential benefit as a natural product, and cost-effective therapeutic option, and hence could be helpful in thromboembolic therapies.

 


Keywords


Keywords: Activated partial thromboplastin time; Adenia cissampeloides; Antithrombotic; Prothrombin time; Pseudocedrela kotschyi; Thromboembolic disease.

Full Text:

PDF

References


Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-394.

DOI: 10.1016/S0140-6736(08)60202-0.

Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1-25.

DOI: 10.1016/j.jacc.2017.04.052.

Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464-474.

DOI: 10.1038/nrcardio.2015.83.

Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129-138.

Van Korlaar IM, Vossen CY, Rosendaal FR, Bovill EG, Cushman M, Naud S, et al. The impact of venous thrombosis on quality of life. Thromb Res. 2004;114(1):11-18.

DOI: 10.1016/j.thromres.2004.04.007.

Eduardo F, Guzmán L, Alarcón M, Moore R, Palomo I. Thrombolytic/fibrinolytic mechanism of natural products. In: Fibrinolysis and Thrombolysis. 2014. pp. 107-121.

DOI:10.5772/57608.

Nili-Ahmadabadi A, Sedaghat M, Ranjbar A, Poorolajal J, Nasiripour H, Ahmadabadi MN. Quantitative analysis and health risk assessment of methanol in medicinal herbal drinks marketed in Hamadan, Iran. J Appl Pharm Sci. 2016;6(7):49-52.

DOI: 10.7324/JAPS.2016.60707.

Paul K. The discovery of dicumarol and its sequels. Circulation. 1959;19(1):97-107.

DOI: 10.1161/01.CIR.19.1.97.

Libby P, Simon DI. Inflammation and thrombosis the clot thickens. Circulation. 2001;103(13):1718-1720.

DOI: 10.1161/01.cir.103.13.1718.

Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005:131(4):417-430.

DOI: 10.1111/j.1365-2141.2005.05753.x.

Khouya T, Ramchoun M, Hmidani A, Amrani S, Harnafi H, Benlyas M, et al. Anti-inflammatory, anticoagulant and antioxidant effects of aqueous extracts from Moroccan thyme varieties. Asian Pac J Trop Biomed. 2015;5(8): 636-644.

DOI: 10.1016/j.apjtb.2015.05.011.

Medeiros VP, Queiroz KCS, Cardoso ML, Monteiro GRG, Oliveira FW, Chavante SF, et al. Sulfated galactofucan from Lobophora variegata: anticoagulant and anti-inflammatory properties. Biochemistry (Moscow). 2008;73(9):1018-1024.

DOI: 10.1134/S0006297908090095.

Nyansah WB, Koffuor GA, Asare F, Gyanfosu L. Anticoagulant effect and safety assessment of an aqueous extract of Pseudocedrela kotschyi (Schweinf.) harms and Adenia cissampeloides (Planch. Ex Hook.) harms. J Intercult Ethnopharmacol. 2016;5(2):153-161.

DOI: 10.5455/jice.20160324054355.

Ma N, Liu XW, Yang YJ, Li JY, Mohamed I, Liu GR, et al. Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model. PLoS One. 2015;10(7):e0133125,1-14.

DOI: 10.1371/journal.pone.0133125.

Liu SQ, Guo JY, Du J, Deng Q, He ZJ, Lin HY, et al. Anticoagulant effect of Huisheng oral solution in a rat model of thrombosis. Indian J Pharmacol. 2013;45(4):359-364.

DOI: 10.4103/0253-7613.115018.

Mousa SA. In-vivo models for the evaluation of antithrombotics and thrombolytics. In: Anticoagulants, Antiplatelets, and Thrombolytics: 2th ed. Totowa, NJ: Humana Press; 2010. pp. 29-107.

DOI: 10.1007/978-1-60761-803-4_2.

Yan F, Yan J, Sun W, Yao L, Wang J, Qi Y, et al. Thrombolytic effect of subtilisin QK on carrageenan induced thrombosis model in mice. J Thromb Thrombolysis. 2009;28(4):444-448.

DOI: 10.1007/s11239-009-0333-3.

Hagimori M, Kamiya S, Yamaguchi Y, Arakwa M. Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model. Pharmacol Res. 2009;60(4):320-323.

DOI: 10.1016/j.phrs.2009.04.010.

Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res. 2008;122(6):743-752.

DOI: 10.1016/j.thromres.2006.10.026.

Musa YM, Haruna AK, Ilyas M, Yaro AH, Ahmadu AA, Usman H. Phytochemical, analgesic and anti-inflammatory effects of the ethylacetate extract of the leaves of Pseudocedrela kotschyi. Afr J Tradit Complement Altern Med. 2008;5(1):92-96.

DOI: 10.4314/ajtcam.v5i1.31261.

Adebiyi OO, Adebiyi OA, Oyeyipo IP, Obembe O, Oladokun O.Aqueous extract of Adeniacissam peloides modulates pain in mice. Int J Pharm. 2013;4(5):918-922.

Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care. 2014;2(1):15-23.

DOI:10.1186/2052-0492-2-15.

Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood. 2004;104(12):3631-3634.

DOI: 10.1182/blood-2004-03-1042.

Kitchens CS. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). Hematology Am Soc Hematol Educ Program. 2009;1:240-246. DOI: 10.1182/asheducation-2009.1.240.

Guerrero JA, Lozano ML, Castillo J, Benavente-García O, Vicente V, Rivera J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost. 2005;3(2):369-376.

DOI: 10.1111/j.1538-7836.2004.01099.x.

Hirsh J, Dalen J, Anderson DR. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119 (1 Suppl):8S-21S.

DOI: 10.1378/chest.119.1_suppl.8s.

González R, Ballester I, López-Posadas R, Suárez MD, Zarzuelo A, Martínez-Augustin O, et al. Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr. 2011;51(4):331-362.

DOI: 10.1080/10408390903584094.

Sadeghi M, Safaeian L, Aghaye Ghazvini M, Ramezani M. Evaluation of fibrinolytic and antioxidant effects of Allium affine hydroalcoholic extract. Res Pharm Sci. 2017;12(4):299-306.

DOI: 10.4103/1735-5362.212047.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.